Jan 20 2023 This Week in Cardiology

Jan 20 2023 This Week in Cardiology

The loop diuretic duels, adverse events during hospital admissions, BP accuracy, and, again, left main revascularization strategies (again) are the topics John Mandrola discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit: https://www.medscape.com/twic

I. TRANSFORM HF

Clarity on Torsemide vs Furosemide in HF: TRANSFORM-HF Published https://www.medscape.com/viewarticle/987128

• Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure https://jamanetwork.com/journals/jama/fullarticle/2800428

• RANSFORM-HF—Can We Close the Loop on Diuretics in Heart Failure? https://jamanetwork.com/journals/jama/fullarticle/2800445

II. Adverse Events in the Hospital

Adverse Events Reported in One Quarter of Inpatient Admissions https://www.medscape.com/viewarticle/987091

• The Safety of Inpatient Health Care https://www.nejm.org/doi/full/10.1056/NEJMsa2206117

III. BP Accuracy

Experts Demand Validation of Automatic Blood Pressure Devices

https://www.medscape.com/viewarticle/987032

IV. Left Main Coronary Artery Disease

Real-World Examination of Revascularization Strategies for Left Main Coronary Disease in Ontario, Canada

https://doi.org/10.1016/j.jcin.2022.10.016

Management of Left Main Coronary Artery Disease in Nonemergent Settings: The Heart of Multidisciplinary Teamwork https://doi.org/10.1016/j.jcin.2022.11.024

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Episoder(396)

Mar 13 2026 This Week in Cardiology

Mar 13 2026 This Week in Cardiology

Beta-blocker in non-obstructive hypertrophic cardiomyopathy, a head-to-head apixaban vs rivaroxaban RCT, diltiazem vs metoprolol combined with DOAC, and the accuracy of smart watches for AF are the to...

13 Mar 31min

Mar 06 2026 This Week in Cardiology

Mar 06 2026 This Week in Cardiology

Listener feedback, urgent AF ablation, AF ablation as a stroke-reducing therapy, implantable loop recorder accuracy, and HF management in the setting of serious disease are the topics John Mandrola, M...

6 Mar 24min

Feb 27 2026 This Week in Cardiology

Feb 27 2026 This Week in Cardiology

A superb note on CPR and DNR orders, patients' vs doctors' preferences for statins, more on GLP-1s, another LAAC story, and some closing cautionary notes on PFA are the topics John Mandrola, MD, discu...

27 Feb 29min

Feb 20 2026 This Week in Cardiology

Feb 20 2026 This Week in Cardiology

EVOLUT Low Risk data, a provocative meta-analysis, DNR orders, targeted hypothermia, good news in HFpEF evidence, and GLP-1s as AF drugs are the topics John Mandrola, MD, discusses in this week's podc...

20 Feb 25min

Feb 13 2026 This Week in Cardiology

Feb 13 2026 This Week in Cardiology

Ticagrelor vs prasugrel, a new LAAC device, pulsed field ablation AF results, lifestyle intervention in AF, the term "provider" vs "doctor," and coffee are the topics John Mandrola, MD, discusses in t...

13 Feb 29min

Feb 06 2026 This Week in Cardiology

Feb 06 2026 This Week in Cardiology

Problems with the PREVENT score, a breakthrough in lipid-lowering therapy, a surprising benefit in stroke care, and more thoughts on statins and preventive care of heart disease are the topics John Ma...

6 Feb 23min

Jan 30 2026 This Week in Cardiology

Jan 30 2026 This Week in Cardiology

Listener feedback, huge news in the rapidly expanding world of PFA AF Ablation, obesity, and a beautiful trial studying an AI-enhanced diagnostic tool in the office are the topics discussed by John Ma...

30 Jan 27min

Jan 23 2026 This Week in Cardiology

Jan 23 2026 This Week in Cardiology

Listener feedback, the value of procedural volume for TAVR and MTEER, ventricular arrhythmia in older athletes, and the Goldilocks time horizon for predicting and modifying CV risk are the topics John...

23 Jan 29min

Populært innen Vitenskap

fastlegen
rekommandert
tingenes-tilstand
forskningno
sinnsyn
rss-rekommandert
smart-forklart
liberal-halvtime
villmarksliv
jss
fjellsportpodden
pod-britannia
vett-og-vitenskap-med-gaute-einevoll
tomprat-med-gunnar-tjomlid
rss-paradigmepodden
psykopoden
dekodet-2
rss-nysgjerrige-norge
nevropodden
rss-overskuddsliv